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Abstract 
Developing a lasting strategy to survive in the African business landscape would be 
incomplete without careful considerations of the role of culture and corruption in the region. 
This chapter aimed at understanding how multinationals operating in the Nigerian 
pharmaceutical landscape in the last fifty years have responded to corruption in the region. 
By conducting eleven in-depth interviews with managers from across different levels of two 
major American pharmaceutical multinationals, the research uncovered a dominant 
bureaucratic culture of compliance. From this culture emerged five different response 
strategies employed by these multinationals in responding to the institutional deficiencies in 
the region. This paper concludes by discussing the likely impact of these on employee moral 
capacities. 









Economic, Social and Institutional Environment 
Nigeria has a population of over 170million people, out of which 20million live in Lagos 
(Central Intelligence Agency, 2013). Lagos state is also the busiest commercial center of the 
nation where most multinationals across all industries are headquartered. The potential for 
economic prosperity in Nigeria has been particularly celebrated globally as Africa’s largest 
economy (Robinson, 2015). Yet amidst this huge prospect, Nigeria’s business landscape still 
faces many challenges. The purpose of this paper is to uncover these contextual challenges, 
how multinationals claim to respond to them as well as the likely moral ramifications of their 
responses. This focus is essential in the light of an increasing necessity to combat systemic 
deficiencies especially corruption at all levels of society for which multinationals are major 
stakeholders, whose activities can either make or mar this course. More interesting is the 
critical role multinationals can play in shaping the moral consciousness of their employees 
who can become useful beyond the walls of these firms. For this, we adopt two American 
firms as case study.  
Research Methodology 
A case study research design was adopted in this study. A crucial advantage of this approach 
is the closeness it offers the researchers to both the context of the study and participants who 
tell their stories. The Nigerian pharmaceutical industry offered the context within which this 
study investigated the phenomenon of corruption and the strategies employed by 
multinationals in responding to issues arising from the context. The choice of the Nigerian 
pharmaceutical industry as the context of this study was predicated on its well-documented, 
recurrent history of scandals and corruption (NAFDAC, 2015) alongside a proven long-term 
operational presence of foreign multinationals in the industry (UNIDO, 2012).  
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Three broad categories of players make the Nigerian Pharmaceutical industry namely: 
Western, Eastern and indigenous firms (IMS Health, 2012). Amongst these, Western firms, 
comprising firms from Europe and America have the longest historical presence in the 
Nigerian pharmaceutical landscape, dating over fifty years (UNIDO, 2012) and were 
therefore the focus of this study. More specifically, this study focused on American 
multinationals amongst the possible array of Western firms for two reasons: First, they 
granted the researchers easy access, which others did not give and second, they met the 
ethical standards employed in this study. Due to the sensitive nature of the pharmaceutical 
industry, anonymity of all participating firms and their employees was crucial at the design 
stage. Given that only British and American firms have an excess of three major players 
within the context, they were the only subsets for which anonymising data was more realistic 
since data containing specific, sensitive information might be easily traceable to its source. 
All British firms approached denied participation in this study, whilst two American firms 
granted access to conduct the study with the assistance of internal leads (employees of these 
firms within the professional network of the researchers).  
Upon gaining access, a mix of stratified and random sampling methods was employed. First 
potential participants within the internal lead’s network were assigned to a group called 
‘lead’s network’ from which simple random sampling followed in selecting part of the final 
sample. To control bias and ensure greater data reliability, participants from outside this 
network were also randomly selected. Overall, eleven employees across low, middle and 
senior management took part in the study. Six of these were within the lead’s network and 
five were outside this network to control bias. 
Then, in-depth semi structured interviews were conducted with all participants, each lasting 
an average of ninety minutes. Questions were structured to facilitate rich discussion on 
internal firm contexts as well as the broader industry and societal contexts in which the firm 
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operated. Using clever ‘how’ and ‘why’ questions, further issues surrounding the responses 
of the firms to the challenges identified were discussed from which interesting insights into 
likely moral ramifications ensued. Gathered data were manually transcribed using a 
combination of software namely: Dragon speech dictator and InqScribed lasting an average 
of 4 hours per interview. Generated texts were imported into NVIVO within which data was 
analyzed using thematic analysis. Thematic Analysis (TA) is ‘a method of identifying, 
analysing and reporting patterns (themes) within data’ (Braun and Clarke, 2006:6). 
Hammerley and Atkinson, (1995) describe TA as aiming to generate descriptions of 
behaviours through identifiable themes and patterns in living and talk. Themes depicting both 
internal firm cultures, broader industry context and ensuing challenges were first observed. 
Then, other themes showing participants’ opinions of how their firms are responding to these 
contextual issues were also observed followed by indications of broader impacts on the 
employees themselves. All these were coded into NVIVO nodes and explored critically in 
generating relevant themes and subthemes. Results and findings from this exercise are 
presented below. 
Findings and Discussions 
The core findings from this study showed that Nigeria has been plagued by weak institutions 
and a culture of corruption as defined by five critical features that emerged as central to the 












Nothing gets done unless the process is ‘helped’ or ‘fast tracked’ and following proper 
procedures is tantamount to a waste of time. Hence, to get things done such as securing a 
major contract, registering a company, clearing an import, and as many other activities as are 
covered in the gamut of the industry’s value chain, people expect to  their way through 
processes to get speedy response. Garuba, Kohler and Huisman, (2009) in a study of the 
Nigerian pharmaceutical industry reported that every aspect of the industry – registration, 
procurement, distribution and so on are susceptible to corruption by up to 89% of the times.  
As a respondent also retorted, 'In Nigeria, things are never straightforward’. This has been 
accepted as the norm and the way business is done; hence different firms have their own 
















Corrupt government officials 
An average government official has a feeling of entitlement and the widespread belief is that 
‘everyone has a price’ hence can be bought over. For instance, labor officials are sent by the 
Federal Government’s Ministry of Labor to check on employee welfare in organizations 
around the country to ensure employers comply with minimum labor conditions as stipulated 
by law.  But this is hardly done. As an employee reported in her interview, “ I know of 
companies where government labor officials get hosted by their bosses, who give them 
branded goods and other gifts. Then they just ask the staff simple questions and never do 
anything about their real complaints’. Yet, economic uncertainties in the country mean 
employees’ choices are limited in securing other jobs; hence they remain at their jobs 
regardless.  
Greed 
There is also a widespread belief that an average citizen is never content and as such is 
always seeking quick money making means even illegal ones as the case may be. For 
instance, pharmaceutical representatives complain many doctors would not prescribe drugs 
unless they are compensated in some way and this pressures them into different unethical 
practices. A medical representative explained, “Doctors are greedy. They put us under a lot 
of pressure. They demand money, sponsorship to international conferences, promotional 
materials, and some even ask that we equip their private clinics with satellite television”. As 
a result, it is common knowledge that some firms buckle under the pressure by putting some 
doctors on paychecks for prescribing certain volume of drugs monthly, whilst also obliging 






A lot of generic drugs have flooded the Nigerian market from different parts of the world. 
This is besides the already stiff competition amongst local and foreign pharmaceuticals 
currently doing business in Nigeria. A manager in one of the firms explained: “ The industry 
is flooded. For malaria alone, there are over 200 drugs that claim to be very effective in 
malaria curative and preventive treatment and other categories of ailments likewise have a 
lot of competing brands from established pharmaceuticals and generic brands.” All these 
force a lot of pharmaceutical representatives to engage outside ethical norms to meet their 
sales targets. The height of this is revealed when doctors pitch pharmaceutical representatives 
against one another to see who will pay them the highest for drug prescriptions without 
necessarily basing their judgment on the quality of the drug or the circumstances of their 
patients. Only multinationals with patented drugs enjoy a lot of immunity in this regard as 
doctors are forced to prescribe their drugs. Competition forces the game to be played outside 
of set rules as implied throughout out this study. 
High Economic Uncertainty 
In spite of anticipated prosperity, a large percentage of Nigerians still live below poverty line 
whilst the fears of economic dividends not trickling to the bottom abounds. This creates 
constant fear in the middle class who feels the pressing need to survive. Most participants 
expressed their fears about the economic uncertainty in Nigeria. In the words of one of the 
participants: “ The job market it tough. Things are tight out there and we really don’t have a 
lot of choices so we have to hang on to what we have now and not lose out eventually”. With 
rising living costs as well as few jobs to match this pressing demand, the sense of insecurity 
has gripped many and kept them glued to whatever jobs they currently have for the fear of 
losing out altogether.  
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The prevalence of these features makes the thought of doing ethical business almost 
impossible yet; several multinationals claim to successfully operate in this context. It would 
therefore be interesting to critically explore how these multinationals strategize to survive in 
Africa.   
Case: American Firms: History, Culture, Practices and Scandals 
American pharmaceuticals are amongst the strongest players in the Nigerian pharmaceutical 
industry in terms of size, market share, profit and historical presence (UNIDO, 2012). With 
over fifty years of well-documented presence in Nigeria, American pharmaceutical 
companies have generally been largely successful (IMS Health, 2012). They have at different 
times owned different drugs production and manufacturing assets locally, diversified into 
veterinary medicine, livestock feed production and so on (Livestock Feed, 2014). Such 
success in a corrupt environment may be commendable from a business perspective; however, 
it also raises curiosity about how these American firms have been able to handle the obvious 
institutional deficiencies identified within the context.  
 
In this section, we examine the internal firm culture and practices of American 
Pharmaceuticals within the context. It is expected that external contexts should strongly 
influence firm culture and also leave clues as to the likely response of firms to the challenges 
of such contexts. Further, we argue that some of the current practices observed in most 
western multinationals within the region may not be entirely isolated from some historical 
antecedents, hence we attempt to link some of these practices with major scandals, for 






Firm Culture and Practices 
A few factors were observed as common threads in the cultural fabric of the understudied 
American multinationals. First, there is a very strong customary culture of compliance to set 
procedures. In fact, all understudied firms consider compliance and strict adherence to set 
standard operating procedures (SOPs) as the biggest ethic any employee must have to survive 
in them. So regimented are internal processes that there is hardly any activity without written 
procedures to them and as such employees are expected to follow these procedures in all 
executions. The strict compliance environment also implies employees caught transgressing 
any set procedure could lose their jobs depending on the level of atrocity committed. These 
features of the firms reveal the bureaucratic tendencies that exist in internal structures for the 
purposes of ensuring employees’ activities are regulated and controlled by set standards as 
multinational enterprises desire to protect their brand reputations.  
 
In practice, this culture of compliance is instilled through frequent, rigorous trainings, with a 
view to exposing employees to case studies that test their ability to effectively apply standard 
operating procedures (SOPs) to real life scenarios. We are however left to question whether 
rules can sufficiently cater for all possible challenges employees face in reality. Also, 
whether explicitly dictating moral reactions to employees who are meant to be fully mature in 
their cognitive moral reasoning (Kohlberg, 1971) does more good to them than harm in the 
long run. From another critical perspective is the issue of effectiveness of written codes, 
which has been reported severally in literature, could help moderate ethical behavior yet 
could also be cleverly employed as a cover to hide unwholesome practices. 
 
Secondly, internal work environments are very structured yet very flexible, cordial and free. 
It was a common expression throughout this investigation in one of the American firms that 
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‘change is the only constant thing’ and therefore change agility is a crucial skill to have on 
the job. You could occupy a position today and the next it is gone leaving such persons to 
apply for other internal positions or leave the firm. Such is the flexibility of internal structures 
that it seems to create an environment of uncertainties and insecurities in some sense. 
Nevertheless, employees described work environment as ‘family’, ‘cordial’ and ‘open’ with 
all employees encouraged to ‘say it as it is’ with zero tolerance for disrespect of colleagues 
and any breach of compliance. Punishments for such are extreme and very harsh, hence as an 
employee, focus is on doing things right.  Reviewing this seemingly friendly environment 
from a critical perspective, it can be argued that this kind of environment could create 
informal mechanisms for normalizing unethical practices and even distracting employees 
from the moral consequences of their actions since their focus would be on pleasing their 
bosses and other employees. In addition, these firms have some of the best welfare packages 
in the industry with employees receiving all possible incentives – new cars, high salaries, 
among others to give security and discourage any unethical practices on the field. However, 
these welfare packages could easily make employees feel indebted to the firms and would 
cause them to go all out to meet their sales target to justify such welfare packages.  
 
Thirdly, in engaging doctors on the field, American MNEs adopt a common practice of 
sponsoring a select few doctors to international conferences and subscribing to medical 
journals on their behalf as contributions towards increasing awareness of global medical 
trends. However, concerns were raised as to the influence these gestures have on doctors who 
may feel indebted to the firms and respond by continually prescribing their sponsor’s drugs. 
But, the American firms claim they insist all doctors sign an agreement that their acceptance 
to be sponsored for a trip abroad is not in any way an inducement to make the doctors 
prescribe company products. They go as far making them declare that these gestures are for 
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their professional development only and that they still maintain full discretion to prescribe 
drugs they feel will help their patients the most. The documentations and processes involved 
are also quite long and tedious for obvious reasons and many doctors have been reported to 
complain bitterly about the processes involved thinking it is almost an insult on their pride. 
Thus, only few are able to wade through the maze to get the prize. The effectiveness of 
signing agreements for such favors remain contestable especially since the favor is expected 
to have induced the doctors in ways beyond any written document, yet many claim not to be 
involved in any form of inducements. But as a participant explained, it is an unwritten rule 
that after doctors benefit from such sponsorship, they will go ahead to prescribe such 
company’s product more. This then raises the tension about the capricious nature of 
relationship between what can be gift giving as different from bribery. 
 
Finally, In contrast to the above, this is an acclaimed zero tolerance to all forms of bribery 
and corruption by these firms. Also, they claim to lay a lot of emphasis on how profit is being 
made over and above the profit itself even if it is at the expense of bottom-line. However, it is 
interesting to note that in spite of these norms and practices, a lot of emphasis is still placed 
on meeting set financial and sales targets as performance is largely based on meeting the 
figures. As profit making entities, the motive is quite clear, and running at a loss would not be 
an option in Africa’s largest market. This therefore gives rise to the question of how MNEs 
can achieve the delicate balance of pressing employees for financial performance in a highly 
competitive and corrupt market whilst expecting them to be completely ethical in the process. 
Also, whilst the strict rule adherence culture may look great on paper, it also raises a few 
practicality issues: can employees always follow set rules in the face of harsh realities on the 
field? More importantly, are the strict rules really aimed at ethical conducts or are clever 
alibis by the firms to exonerate themselves from any scandal, whilst still allowing for some 
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dirty play in the field by their employees? Looking back at history, we argue that regardless 
of the ploy by these firms either to really want to do ethical business or just to cover up their 
tracks whilst doing business as usual, a few factors may be responsible for this culture. One 
of such is a historic scandal that rocked Pfizer in 1996 in the Northern part of the country and 
has since left the company trying to recover.  After years of legal battle, it can be argued that 
part of the response of Western multinationals to the scandal in addition to foreign 
regulations governing their activities was the tightening of internal processes through 
rigorous standard operating procedures (SOPs). Yet the full motives and effectiveness of this 
practice is highly debatable. 
 
Pfizer Kano Scandal 
In 1996, following the outbreak of cerebral meningitis in Kano, a northern city in Nigeria, 
Pfizer reportedly moved in first hand inside few weeks of the outbreak to administer a drug, 
Trovan on infected children. Trovan was in its last stages of development and a test on 
human specimen would validate its potency as a potential ‘blockbuster’ drug as had been 
predicted in Wall Street (Stephens, 2000). However the clinical trial was soon riddled with 
lots of controversies including the death of many children and the deformity of several others. 
Arguments surrounding Pfizer’s actions have generally been categorized as either a genuine 
move to save lives or a greedy drive to make profit, with evidences skewing more towards 
the later than the former. First, Trovan had been predicted would generate $1billion in 
revenue (Brichacek, 2001). Given the huge sums that go into drug development often 
spanning ten years of more, a real time epidemic offered the perfect platform to test the drug, 
get final approvals for global deployment and make predicted profits. Further investigations 
soon also revealed Pfizer had falsified consent letters to carry out the trial, that they had 
administered lesser doses than required by law and that the parents of the victims were not 
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properly informed before their children were administered the unregistered drugs (Abdullahi, 
2002). A parent famously retorted, ‘The Americans and some local doctors gave Anas this 
evil drug’ (Murray, 2007).  
Furthermore, a World Bank report in 2002 ascribed the scandal to the repressive and corrupt 
military regime of the era, which had weakened all institutions, including the drug regulatory 
agency in Nigeria, rendering it incapacitated to carry out its statutory duties of protecting 
lives (World Bank, 2002). This made it possible for Pfizer to obtain ‘quick’ permissions from 
the authorities without any delays, although it can be argued that the urgency of the matter 
could have contributed to this. Initial response to the epidemic by a charity medical 
organization in the region was administering another antibiotic, which was reported, had 
some success (Murray, 2007). But it was the allegation that Pfizer kept the children on their 
drugs even when improvements were not observed that further accentuated their motive in 
the trial. Pfizer, (2007a) in response to accusations claimed Trovan reduced mortality rates 
from 20% to 10% and that they sought oral consents due to low literacy in the region using 
interpreters to communicate their intentions to parents. Pfizer also claimed to have sought 
appropriate consent from regulatory authorities and insisted that ‘Trovan helped save lives’ 
(Pfizer, 2007b:1). Finally, Pfizer denied that Trovan was responsible for the death of the 
children in question but that the disease killed them coupled with the fact that they had 
supported the state government with 18million Naira in contributions and support towards the 
epidemic. 
Whilst Pfizer would not claim responsibility for the children’s deaths and insisted their 
actions were ‘ethically justifiable’ the company suppressed every attempt to allow a fair 
hearing of a lawsuit leveled against them in the United States until 2008 when a $7 billion 
lawsuit filed by the Nigerian government led to Pfizer’s indictment (Goldacre, 2013). Pfizer’s 
actions and responses opened up several debates but what is of more interest in this study is 
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the real motive of the firm and whether opportunistic behaviors have been at the foundation 
of their success in Nigeria in the past. In retrospect, had the trial gone smoothly, the firm 
would still look great on paper as an ethical firm doing good business in the region, yet this 
one scandal brought to light the real issues. Interestingly also, Pfizer diversified all its 
investments in Nigeria in 1997 and reduced its activities to merely marketing and distribution 
in the region. The coincidence of this divestment with the Kano scandal must not be ignored 
because in 1997, the scandal was about to gain global attention and as such it can be argued 
that the divestment was a move by Pfizer to play safe knowing fully well the like 
consequences of the drug trial on its reputation when it gained global attention. Yet, 
completely pulling out from the region was not an option knowing fully well the potential 
impact of the Nigerian market on firm’s bottom line. Thus, if survival in Africa would 
include such opportunistic behaviors, the use of brand power to buy corrupt government 
officials amongst other unwholesome practices, it can be argued that every other firm culture 
in place today as earlier discussed may just be mere facades masking the real issues or may 
simply be defense mechanisms aimed at protecting the firm from any legal troubles but does 
not position the firm for consistent ethical behavior within the context. 
Therefore, given the capricious business environment previously described and the cultural 
traits, practices and scandal explored in this section, we are able to further appreciate the 
nature of the complex relationships that exists between multinationals and the corrupt 
contexts of host countries. Whilst there may not be a singular potent tactic able to help firms 
make decent profit ethically from a highly profitable market, the adoption of the dominant 
stringent SOP tactic still does not completely protect them from falling prey to traps of the 
system, at least for firms willing to do business ethically. Yet, on another note is the reality 
that contrary to the claims of several multinationals in the industry that they conduct business 
ethically, their acclaimed response strategies may simply be mere propaganda. 
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Responses to the Institutional Landscape and broader Moral Implications 
Following from the previous section, there are five major ways American firms claim to 
respond to the aforementioned institutional challenges in Nigeria based on their strong culture 
of compliance as follows:  
Avoidance  
Employees are instructed to select the people and places where they profitably do their 
business to meet their targets with little or no efforts. As a result, representatives are expected 
to know hospitals and clinics that are loyal to their brand and will prescribe company brands 
with little or no persuasion. By this they are expected to know and avoid problematic and 
corrupt doctors in their territories.  
Firmness  
Even when probed to bribe, many employees have said they have stood their grounds on the 
fact that they don’t in any way feel the doctors are doing them a favor but vice versa. The 
doctors have a primary objective - to save lives and when this is achieved, it is great for their 
image. That objective is what the pharmaceutical companies are also out to help them achieve.  
Brand Power  
With patented drugs in the market, American pharmaceuticals have a strong bargaining 
power when they have the only drug in the market able to cure particular diseases in certain 
ways. With this, the doctors have no power to ask for bribes and representatives are asked to 
leverage this in doing business. However there is a possibility of firms leveraging this power 
excessively as has been experienced in South Africa, where pharmaceutical giants have been 
accused of suppressing of bills that would grant local manufacturers the right to produce 
generic versions of cancer drugs, thereby making them affordable for the masses (Rutter, 
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2014). Similarly, in the Trovan case earlier described Pfizer leveraged on its power to gain 
quick access to the disease ravaged part of a country for the clinical trial and also leveraged 
the same for the subsequent suppression of lawsuits brought against it. However, the critical 
issue is how firms choose to use their brand power in any given context. 
Creativity  
With lots of competing generics, employees in American MNEs are rewarded for ingenuity 
and innovativeness in approaching the market to do clean business. Some of the ways they 
have done this include developing special screening schemes in partnership with state 
governments after which the treatment of infected persons are paid for. Sponsorship of 
conferences both local and international, supply of medical journals to doctors and hospitals 
etc. Essentially exploiting the gift giving culture of the country with loyal clients with the 
claims of adding value to the knowledge of the medical professionals.  
Relationships  
Medical representatives thrive a lot on long standing relationships with medical professionals 
over the years such that they keep recycling business as a result.  Even when such 
representatives change jobs to other companies, they attempt to leverage on those 
relationships to sell their new company’s products. 
Thus, in adopting these strategies, firms feel safe navigating through the difficult business 
terrain, yet, there are some broader moral implications these strategies raise. First, whilst it 
seems clear that the purpose of the firms is primarily to make as much profit in the region, the 
corrupt context also seems to place a demand on corporations to help mold morally 
responsible citizens, if they are truly to be worthy examples of good corporate citizens to 
their host country. In principle, this may be farfetched and creating a strict compliance culture 
has been proven could be doing more harm than good to the moral development of 
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employees (Ferrell and Skinner, 1988; Weber, 1990). We explore this further in the next 
section. 
Impact on Employee Morality 
Organizational rules including code of ethics are a part of the formal structure in 
organizations. They could help define relationships and guide activities thereby creating sets 
of mutual expectations as well as reducing uncertainties (Zhou, 1993). Organizational 
researchers have highlighted the tendency of huge multinationals, to avoid and reduce 
uncertainty especially those operating in heterogeneous task environments (Henisz and 
Delios, 2002; Ghoshal and Nohria, 1989) and environments with uncertainties (Das, 1983) by 
using formalized rules as is the case in this study. They could also be used as tools in creating 
compliant employees enforced by rewarding obedience and punishing violations. From an 
ethics perspective for instance, rules could be very useful in shaping moral capacity in 
employees and have often been argued to grant organizations more control over the ethical 
behaviors of their employees (Ferrell and Skinner, 1988). Ferrell and Skinner, (1988) in their 
study concluded that formalization explained the most variance in ethical behavior with the 
existence of an ethical code as the major factor explaining the variation. In affirmation, 
corporate policies, usually codes of ethical conduct have also been linked to increased ethical 
conduct (Ferrell and Weaver, 1978; Fritzsche and Becker, 1983; Hunt, Chonko, and Wilcox 
1984). Also, Tsalikis and Fritzche, (1989), Murphy, Smith and Daley, (1992) concluded in 
their studies that corporate ethics inhibits unethical behavior and that employees in these 
organizations were less aware of unethical or illegal activity in their organizations. But whilst 
this could be a positive, the fact that moral awareness is reduced is a major point of criticism, 
whereby employees’ individual moral agency is replaced by rules thereby limiting their 
capacity to recognize moral issues and ability to make sound judgments. Therefore, this has 
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often raised concerns about the presence of code of ethics being a mere façade to mask the 
real ethical issues and struggles in organizations.   
However, in practice, formalized rules have also been reported to activate role conflict among 
professionals because of the discrepancy that exists between their personal norms and the 
organization’s (Organ and Greene, 1981). This is also known to create a moral tension 
between employees and their organization. Merton, (1968) further explained that often times 
the presence of formalized rules implies the need to strictly adhere to those rules, a behavior 
called compliance. He then argued that the impact of compliance on employees is that 
following the rules becomes an end in itself and could cause them to lose focus of the bigger 
goals of the organization or the moral consequences of their actions especially where such 
rules are used by firms towards unethical ends. 
Furthermore, Kohlberg’s cognitive moral development theory offers key insights into the 
moral ramifications of the rule-based morality. According to Kohlberg’s, (1971) typology of 
cognitive moral development, rule based morality places individuals at the pre conventional 
level of moral reasoning. At this basic level of moral reasoning, morality is defined in terms 
of avoiding to break the rules (Colby and Kohlberg, 1971), beyond which every other 
concern is obliterated. Employee orientation would be on reward, punishments and obedience 
only. However, Kohlberg’s categorizations suggest higher levels of moral development, that 
is the conventional and post conventional stages are more adequate in resolving significant 
moral dilemmas (Kohlberg, 1975) than the lower pre-conventional level. Therefore, 
Kohlberg’s theory argues that at the pre conventional level firms with strict rules expect 
employees’ orientation to be towards keeping set rules, a reasoning level that renders them 
incapable of making critical moral judgments. Whereas, anyone reasoning at the higher 
stages could for example recognize a moral issue and make a decision to leave the job based 
on the violation of some higher moral principle they hold in high regard. As such Kohlberg’s 
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theory would presume from a moral standpoint that strict rule compliance in organizations 
creates a false conscience and a rule based moral code that keeps employees bound at a lower 
level of cognitive moral maturity. Hence, moral capacity to see moral issues and make 
autonomous moral judgment is significantly curtailed. 
This position has been substantiated by some empirical studies. For instance, Weber, (1990) 
in his study of moral reasoning among managers in response to three distinct moral dilemmas 
discovered that managers typically reasoned at the conventional level, implying they thinking 
is done at the level of conformity to organization norms without consideration for broader 
moral implications. Weber, (1990) also discovered in his study that managers that worked in 
large organizations reasoned as a considerably lower level than those working in small self-
employed firms thereby validating the role rules play in limiting moral capacity of employees. 
Also in a review of ethical decision making literature by Loe, Ferrell and Mansfield, (2000), 
seventeen studies were found to have understudies the role of code of ethics in decision-
making. Results varied from those who found code of ethics as useful to the improvement of 
ethical behavior (Weaver and Ferrell, 1977) to those who discovered it increased a sense of 
awareness and subsequent reporting of unethical incidents (Trevino and Youngblood, 1990; 
Valentine and Barnett, 2002) and to those who concluded it was less effective in helping 
ethical behaviors (Bruce, 1994; Glenn and Van Loo, 1993). However, Beneish, and Chatov, 
(1993) opined the contents of code vary according to industries and this could explain the 
variations in the findings. Ultimately, the ends for which rules are created is the critical factor 
in determining their success in organizations. 
Summary and Conclusion 
This study has explored the difficult business terrain of Nigeria and the response of firms to 
the context in different forms. Whilst it was clearly established in the course of this study that 
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the nature of business environment makes it almost impossible to do ethical business, it was 
also quickly established that most firms might be playing to the gallery by claiming to have 
the best practices of doing business in the country. Exploring this further, the Pfizer scandal 
shed more light into the likely unethical practices that may be happening behind the scenes 
within the organizations and we argued that the prevalent firm practices might simply be 
clever strategies to mask the moral lapses of these firms. Whilst there may not be clear-cut 
solutions to doing clean business in Africa giving the difficult terrain, a few critical thoughts 
come to mind: Are multinational firms actually exploiting contextual weaknesses to fatten 
their bottom lines and if not, is it possible to do business in such an environment without 
getting involved in the corruption at all levels? Whilst we may not be able to exhaustively 
answer these questions in this study, yet another interesting point is the thin line between the 
gift-giving culture in Africa and bribery. At what point can a gift be termed a bribe?  
Though within the pharmaceutical industry, the ethical problem of ‘inducing’ doctors and 
other potential business sources has been a bone of contention, some multinationals believe in 
securing their businesses first before any exchange of gifts takes place. Any form of gift 
giving to doctors by the multinationals in the form of subscription to medical journals, 
sponsorship to international conferences, giving free drug samples etc. can be argued already 
secures the goodwill of that firm with the doctors such that it takes perhaps a far greater treat 
from another company to convince the doctors otherwise. So prescription of drugs may no 
longer be based on the science of such drugs. And if financial muscle is anything to go by, 
multinationals stand the better chance of winning doctors over coupled with their already 
established brand name amongst other key factors. These are some of the grey issues that also 
typify the Nigerian business landscape. However as also discovered, corporations could 
endeavor to make raising morally responsible citizens a priority by shifting the focus of their 
response strategies especially using strict rules not only to cater for their profit needs but also 
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in deliberately molding morally responsible citizens able to think independently and respond 
properly to moral issues. Also, barring greed, which is yet another major issue in capitalist 
economies, western pharmaceuticals can and should leverage their brand power to set 
positive examples for how ethical business can be done in the region.  
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